COVAX

    At the start of 2022, more than nine billion doses of coronavirus vaccines had been administered in 197 countries, but still only 50% of the global population is fully vaccinated. The global spike in Omicron cases is showing that no one is safe until everyone is safe. The COVAX program, which aims to ensure more equitable access, has shipped almost a billion vaccines, but the challenge remains colossal. Now a new, unpatented vaccine called CORBEVAX, using recombinant protein-based technology which is cheaper and more scalable in production, is set to launch, first in India with other countries to follow.

    — Wayne Visser

    More on Society & Justice

    From Purpose Inspired: Reflections on Conscious Living, Volume 5. Buy on Lulu ↗